Skip to main content

Find Clinical Trials

Home
Conditions
Tobacco Use Disorder

Clinical trial condition

Tobacco Use Disorder

Explore clinical trials studying Tobacco Use Disorder. Study availability and eligibility vary by location and protocol.

860 public trials 82 recruiting studies

Refine in advanced search Browse all conditions

Tobacco Use Disorder trial results

Completed

Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?

NCT00846859

Conditions: Alcohol Dependence, Alcohol-Related Disorders, Alcoholism, +6 more
Locations: Addiction Biology Unit, Beroendekliniken, University of Gothenburg and Sahlgrenska University Hospital Gothenburg, Sweden

Beroendecentrum, Malmö University Hospital (UMAS), Sweden Malmö, Sweden

Department of Clinical Neuroscience Section of Dependence Research Magnus Huss Clinic: M4:02 Karolinska University Hospital Stockholm, Sweden

View Trial Details

Completed

Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder

NCT01093937

Conditions: Behavior, Bipolar Disorder, Bipolar and Related Disorders, +7 more
Locations: Centre for Addiction and Mental Health Toronto, Ontario, Canada

View Trial Details

Completed

Effects of Varenicline on Brain Activity During Nicotine Abstinence

NCT00602927

Conditions: Chemically-Induced Disorders, Mental Disorders, Nicotine Dependence, +2 more
Locations: Tobacco Use Research Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Testing Methylphenidate for Smoking Abstinence

NCT00549640

Conditions: Behavior, Chemically-Induced Disorders, Mental Disorders, +3 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

St. John's Wort for Tobacco Cessation

NCT00405912

Conditions: Behavior, Chemically-Induced Disorders, Mental Disorders, +4 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Fresh Lime Alone for Smoking Cessation

NCT01333202

Conditions: Behavior, Chemically-Induced Disorders, Health Behavior, +4 more
Locations: Panyananthaphikkhu Chonprathan Medical Center Ban Plak Raet, Nondhaburi, Thailand

View Trial Details

Completed

Direct to Smoker Outreach in a Health Care Setting

NCT01321944

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance-Related Disorders, +2 more
Locations: Revere Health Center Revere, Massachusetts, United States

View Trial Details

Completed

Effects of Chantix on Relapse Prevention for Smoking Cessation

NCT00948649

Conditions: Chemically-Induced Disorders, Mental Disorders, Nicotine Dependence, +2 more
Locations: Tobacco Use Research Center, University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia

NCT00495352

Conditions: Chemically-Induced Disorders, Mental Disorders, Schizophrenia, +4 more
Locations: Yuli hospital, DOH Yuli Townhsip, Taiwan

View Trial Details

Completed

Emergency Department Telephone Quitline

NCT00394420

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance-Related Disorders, +2 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details